Apple Watch Series 12 Loses Hypertension Notifications in 33 Countries

Apple has confirmed that upgrading to the Apple Watch Series 12 or the Apple Watch Ultra 4 could mean losing access to hypertension notifications, at least for now. The warning is buried on Apple’s own watchOS feature availability page, and it affects buyers in 33 countries and regions around the world.

According to Apple’s support documentation, hypertension notifications may not be available on the Apple Watch Series 12 or the Apple Watch Ultra 4 in certain regions because additional regulatory clearances for these devices are still in process. That means anyone in an affected country who currently relies on this feature could lose it the moment they switch to one of the new models, at least until Apple secures the necessary approvals.

Apple Watch Series 12 lifestyle 02 260909

Which Countries Are Affected

The list of 33 affected countries and regions includes Canada, Australia, India, Brazil, Singapore, Japan, Taiwan, South Africa, South Korea, and the United Arab Emirates, along with several others that Apple has listed in full on its website. If you live in one of these markets and depend on hypertension notifications, it’s worth checking Apple’s feature availability page before you upgrade.

The root cause comes down to hardware changes rather than a software rollback. Both the Apple Watch Series 12 and the Apple Watch Ultra 4 ship with a redesigned Health Sensing System that includes new optical and electrical heart sensors, and those changes appear to trigger a fresh round of regulatory review in several markets.

Here’s what actually changed under the hood on these new models:

  • ECG: The electrodes now cover more surface area, which improves skin contact and should make ECG readings more consistent and reliable.
  • Optical sensing: Apple redesigned the photodiodes and arranged them in a ring layout so the sensor captures light more efficiently than before.
  • Heart rate measurement: Larger, more power-efficient green LEDs in the optical heart rate sensor let the new watches measure heart rate every five seconds throughout the day, which feeds into more accurate Exercise and Move Activity rings along with real-time readings in the updated Heart Rate app. Heart rate variability is now measured as often as every five minutes as well.

Those upgrades are a genuine improvement for anyone who cares about fitness and health tracking, and they’re part of why the Apple Watch Series 12 and the Apple Watch Ultra 4 are being positioned as meaningful health tracking upgrades this year rather than a simple spec bump. The tradeoff is that new sensor hardware often needs to clear new regulatory hurdles country by country, and that process doesn’t always line up neatly with a product launch date.

What This Means If You’re Upgrading

If you already own an Apple Watch that supports hypertension notifications and you’re planning to upgrade to the Apple Watch Series 12 or the Apple Watch Ultra 4, the practical impact depends entirely on where you live. Buyers in the United States, the United Kingdom, and across the European Union should see no change at all, since these regions aren’t on Apple’s affected list.

Buyers in one of the 33 listed countries should expect a temporary gap. Apple hasn’t given a timeline for when the missing regulatory clearances will come through, so anyone in an affected region who relies heavily on this feature might want to hold off on upgrading until Apple provides an update, or at least go in knowing the notifications won’t be there on day one.

This isn’t the first time Apple has had to stagger a health feature rollout by region while it works through local regulatory requirements, and it likely won’t be the last. It does serve as a useful reminder that Apple’s health features aren’t universal on release day, even when the hardware itself ships everywhere at once.

FAQ

Will hypertension notifications come to my country eventually?
Apple hasn’t given a firm timeline, but the language on its feature availability page frames this as a regulatory clearance still in process rather than a feature that’s been pulled permanently.

Is the United States affected by this?
No. The United States, the United Kingdom, and all EU countries are not on Apple’s list of affected regions, so hypertension notifications will keep working as normal after upgrading to the Apple Watch Series 12 or the Apple Watch Ultra 4.

Does this affect other health features on the new Apple Watch models?
Apple’s statement is specific to hypertension notifications. There’s no indication that other health tracking features, including ECG or heart rate monitoring, are affected by the same regulatory delay.

Newsletter
Never miss an Apple story
One email a day, the news that matters. No spam, unsubscribe anytime.
About the Author

Imran Hussain is the founder and editor of iThinkDifferent, which he launched in 2008 to cover Apple news, reviews, and how-to guides. He has spent over 15 years writing about iOS, macOS, and the wider Apple ecosystem, with a focus on hands-on guides - installing developer betas, troubleshooting, and walking through new features on his own devices. Based in Dubai, he also loves to cover photography, gaming, and the tech industry more broadly on his social media profiles.

Leave a Reply